October 17, 2017
Scientists from For-Robin Inc., a University at Buffalo biotechnology spinoff, have published new research results showing that the company’s cancer-fighting antibody can target, penetrate and kill human tumor cells effectively. The findings, reported in September in the journal Neoplasia, bring the company one step closer to human clinical trials. “This is a […]
